ARS Pharmaceuticals, Inc. (SPRY) Q2 2026 Earnings Call Transcript
· seekingalpha.com
ARS Pharmaceuticals, Inc. (SPRY) Q2 2026 Earnings Call August 13, 2026 4:30 PM EDTCompany ParticipantsDonn Casale - CEO, President & DirectorKathleen...
Presentation
Please be advised that today's conference is being recorded. I will now turn the call over to Monique Allaire, IR representative for the company. ...